Bill

Bill > S821


NJ S821

NJ S821
Requires hospitals to provide breast cancer patients with information concerning reconstructive surgery; prohibits certain provisions in managed care plan contracts.


summary

Introduced
01/14/2020
In Committee
01/14/2020
Crossed Over
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill requires general hospitals that provide surgical services for the treatment of breast cancer, the breast cancer gene, or other breast abnormality, including, but not limited to, mastectomy surgery, lymph node dissection, or lumpectomy, to ensure that breast cancer patients are provided written notice of the patient's right to seek a consultation with a board-certified plastic surgeon of the patient's choosing who provides reconstructive services concerning the patient's treatment options during and after the provision of surgical services, including the use of a prosthesis and the option of undergoing reconstructive surgery either during, or after receiving, surgical treatment for breast cancer, the breast cancer gene, or other breast abnormality, as well as the patient's right to obtain such services, regardless of the plastic surgeon's hospital affiliation or network participation. Patients are also to be provided with written notice concerning the availability of coverage under a health benefits plan for reconstructive surgery pursuant to State and federal law. The written information is to be provided to the patient when the hospital is notified of the patient's breast cancer diagnosis and in advance of obtaining consent to the surgical procedure. The bill also supplements the "Health Care Quality Act" to provide that a contract between a carrier and a health care provider for network participation will not contain any provision that prohibits or limits a health care provider in making recommendations or referrals for a covered person to a board-certified plastic surgeon, regardless of network affiliation, who provides the full scope of breast reconstructive services necessary and appropriate to the patient's treatment needs, as determined by the patient's treating physician based on the plastic surgeon's training, experience, and location in relation to the patient's primary residence, provided that the primary consideration in making such recommendations and referrals is the patient's treatment needs. Carriers will not be permitted to deny authorization for reconstructive surgery and related services based on the plastic surgeon's network status or hospital affiliation. The provision applies to reconstructive breast surgery or surgery to restore and achieve symmetry between two breasts following treatment or surgery for breast cancer, the breast cancer gene, or other breast abnormality, including, but not limited to, mastectomy surgery, lumpectomy, or radiation. For purposes of the bill, the term "carrier" means a carrier as used in the "Health Care Quality Act," P.L.1997, c.192 (C.26:2S-1 et seq.), as well as the State Health Benefits Program and the School Employees' Health Benefits Program.

AI Summary

This bill requires hospitals that provide breast cancer treatment, such as mastectomy, lymph node dissection, or lumpectomy, to inform patients of their right to consult with a board-certified plastic surgeon, regardless of the surgeon's hospital affiliation, about reconstructive surgery options during and after the treatment. The bill also prohibits insurance contracts from limiting healthcare providers' ability to refer patients to out-of-network plastic surgeons for necessary reconstructive services, and it prohibits insurance carriers from denying coverage for such services based solely on the plastic surgeon's network status or hospital affiliation.

Committee Categories

Health and Social Services

Sponsors (5)

Last Action

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 01/14/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...